Browse studies

Find your next paid study

3,232 recruiting studies matching your filters

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

International registry for cancer patients evaluating the feasibility and clinical utility of an Artificial Intelligence-based precision oncology clinical tria…

Cancer, MetastaticCancerCancer of Pancreas+40 more

Estimated

~$10 – $1,050

Actual pay is set by the research site.

Massive Bio, Inc.NCT03452774

Observational

TRANBERG® Transperineal MR/US Focalyx Fusion Laser--Induced Thermal Therapy in the Office Setting Under Local Anesthesia

This study is set up as a phase I prospective, single center, device interventional pilot study carried in office setting under local anesthesia. It will asses…

Prostate CancerAdverse Effects SurgeryMRI+6 more

Estimated

~$10 – $1,050

Actual pay is set by the research site.

Urological Research Network, LLCNCT05698576

Collection of Urine Samples to Support the Bladder EpiCheck Product Development Studies

This is a prospective, observational study to support the development of the Bladder EpiCheck kit by collecting urine samples from subjects suspected to have a…

Suspicion of Bladder CancerNMIBC Surveillance

Estimated

~$10 – $1,050

Actual pay is set by the research site.

Nucleix Ltd.NCT07514143

Phase 1

A Phase 1 Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Antitumor Activity of NDI-219216 in Patients With Advanced Solid Tumors With/Without Microsatellite Instability and/or Deficient Mismatch Repair

The goal of this clinical trial is to learn if NDI-219216 is safe for patients, and if NDI-219216 might be a possible treatment for advanced solid tumors in th…

Advanced Solid Tumors CancerMSI-H Cancer

Estimated

~$150 – $4,200

Actual pay is set by the research site.

Nimbus Wadjet, Inc.NCT06898450

Phase 2

GLP-1R Agonist Treatment for Opioid Use Disorder

The goal of this clinical trial is to learn if semaglutide can reduce illicit opioid use in adults in outpatient treatment for opioid use disorder, and who are…

Opioid Use DisorderOpioid Abuse and AddictionNarcotic-Related Disorders+4 more

Estimated

~$75 – $2,000

Actual pay is set by the research site.

Milton S. Hershey Medical CenterNCT06548490

Phase 2

A Phase II, Multicenter, Open-label, Single Arm Study to Evaluate the Safety and Efficacy of Asciminib in Pediatric Participants Newly Diagnosed or Previously Treated With Philadelphia Positive Chronic Myelogenous Leukemia in Chronic Phase (Ph+ CML-CP) With or Without Known T315I Mutation

The aim of this study is to support development of asciminib in the pediatric population (1 to \< 18 years) with Ph+ CML-CP. The study will evaluate the effica…

Chronic Myelogenous LeukemiaLeukemia, Myelogenous, Chronic, Philadelphia Chromosome Positive

Estimated

~$75 – $2,800

Actual pay is set by the research site.

Novartis PharmaceuticalsNCT07354074

Phase 1

A Phase Ib/Phase II Trial With Capivasertib Plus Immunotherapy in Bladder Cancer

This study aims to determine whether adding an oral medication called Capivasertib to ongoing immunotherapy can enhance treatment responses in patients with ad…

Advanced Urothelial Carcinoma

Estimated

~$150 – $2,700

Actual pay is set by the research site.

VA Office of Research and DevelopmentNCT07793578

Observational

A Phase 2 Study of Short Interval Postoperative Stereotactic Body Radiation Therapy (SBRT) After Surgical Intervention for Spine Metastases

Current guidelines suggest postoperative spine Stereotactic Body Radiation Therapy (SBRT) should be delivered within 2-4 weeks after surgery. This approach is …

Spine MetastasisStereotactic Body Radiation Therapy (SBRT)

Estimated

~$10 – $675

Actual pay is set by the research site.

University of California, San FranciscoNCT07346170

Phase 1

A Phase 1, Randomized, Double Blind, Placebo-Controlled, Single Ascending Dose Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of SAB01 in Healthy Participants

SAB01 is an investigational bispecific monoclonal antibody targeting mast cells. This first-in-human Phase 1 clinical trial evaluates the safety, pharmacokinet…

Healthy Adult Participants

Estimated

~$500 – $11,250

Actual pay is set by the research site.

Santa Ana BioNCT07815561

Establishing a ctDNA Biomarker to Improve Organ Preserving Strategies in Patients With Rectal Cancer

This study measures the levels of circulating tumor DNA (ctDNA) in patients with stage II-III rectal cancer before, during, and after treatment to find out if …

Rectal AdenocarcinomaStage II Rectal Cancer AJCC v8Stage IIA Rectal Cancer AJCC v8+6 more

Estimated

~$10 – $1,125

Actual pay is set by the research site.

OHSU Knight Cancer InstituteNCT05081024

Phase 2

MC220503 Randomized Phase II Rescuing Cancer Immunotherapy With Plasma Exchange in Bladder Cancer 1 (ReCIPE-B1)

This phase II trial compares therapeutic plasma exchange followed by enfortumab vedotin and pembrolizumab to standard of care next-line therapy for the treatme…

Metastatic Bladder Urothelial CarcinomaMetastatic Renal Pelvis and Ureter Urothelial CarcinomaRefractory Bladder Urothelial Carcinoma+3 more

Estimated

~$75 – $2,000

Actual pay is set by the research site.

Mayo ClinicNCT07087860

Phase 2

A Pragmatic Phase II Study Evaluating Tolerability in Prostate Cancer Patients Treated With Abiraterone + Prednisone or Darolutamide

This phase II trial compares the effects, good and/or bad of abiraterone and prednisone or darolutamide alone in treating patients with prostate cancer that ma…

Advanced Prostate AdenocarcinomaStage III Prostate Cancer AJCC v8Stage IV Prostate Cancer AJCC v8

Estimated

~$75 – $2,000

Actual pay is set by the research site.

University of California, DavisNCT06173362